[go: up one dir, main page]

GB0203297D0 - Novel composition - Google Patents

Novel composition

Info

Publication number
GB0203297D0
GB0203297D0 GB0203297A GB0203297A GB0203297D0 GB 0203297 D0 GB0203297 D0 GB 0203297D0 GB 0203297 A GB0203297 A GB 0203297A GB 0203297 A GB0203297 A GB 0203297A GB 0203297 D0 GB0203297 D0 GB 0203297D0
Authority
GB
United Kingdom
Prior art keywords
novel composition
novel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0203297A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0203297A priority Critical patent/GB0203297D0/en
Publication of GB0203297D0 publication Critical patent/GB0203297D0/en
Priority to PE2003000145A priority patent/PE20030800A1/en
Priority to MYPI20030447A priority patent/MY139719A/en
Priority to UY27660A priority patent/UY27660A1/en
Priority to ARP030100422A priority patent/AR038417A1/en
Priority to TW092102772A priority patent/TWI286079B/en
Priority to NZ534152A priority patent/NZ534152A/en
Priority to KR1020107015064A priority patent/KR20100086084A/en
Priority to AU2003245763A priority patent/AU2003245763B2/en
Priority to PL371368A priority patent/PL206596B1/en
Priority to DE60331041T priority patent/DE60331041D1/en
Priority to SI200331764T priority patent/SI1474114T1/en
Priority to EP03739557A priority patent/EP1474114B1/en
Priority to AT03739557T priority patent/ATE455540T1/en
Priority to DK03739557.1T priority patent/DK1474114T3/en
Priority to CNB038037378A priority patent/CN100444833C/en
Priority to MXPA04007794A priority patent/MXPA04007794A/en
Priority to KR1020047012361A priority patent/KR101048925B1/en
Priority to ES03739557T priority patent/ES2336319T3/en
Priority to CA002475544A priority patent/CA2475544A1/en
Priority to APAP/P/2004/003087A priority patent/AP1736A/en
Priority to BRPI0307319A priority patent/BRPI0307319B8/en
Priority to PCT/GB2003/000594 priority patent/WO2003068195A1/en
Priority to EA200401071A priority patent/EA008286B1/en
Priority to JP2003567378A priority patent/JP2005526031A/en
Priority to CN2008101748461A priority patent/CN101411693B/en
Priority to OA1200400209A priority patent/OA12770A/en
Priority to PT03739557T priority patent/PT1474114E/en
Priority to IL163098A priority patent/IL163098A/en
Priority to IS7383A priority patent/IS2747B/en
Priority to CO04077244A priority patent/CO5601025A2/en
Priority to EC2004005232A priority patent/ECSP045232A/en
Priority to MA27822A priority patent/MA27689A1/en
Priority to NO20043633A priority patent/NO334453B1/en
Priority to HK05103523.5A priority patent/HK1072194A1/en
Priority to CL2007003010A priority patent/CL2007003010A1/en
Priority to CY20101100304T priority patent/CY1109939T1/en
Priority to JP2010098906A priority patent/JP5279757B2/en
Priority to US12/966,323 priority patent/US9144547B2/en
Ceased legal-status Critical Current

Links

GB0203297A 2002-02-12 2002-02-12 Novel composition Ceased GB0203297D0 (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
GB0203297A GB0203297D0 (en) 2002-02-12 2002-02-12 Novel composition
PE2003000145A PE20030800A1 (en) 2002-02-12 2003-02-10 CONTROLLED RELEASE ORAL DOSAGE FORM
MYPI20030447A MY139719A (en) 2002-02-12 2003-02-10 Oral dosage form for controlled drug release
UY27660A UY27660A1 (en) 2002-02-12 2003-02-11 NEW COMPOSITION
ARP030100422A AR038417A1 (en) 2002-02-12 2003-02-11 ORAL DOSAGE FORM, PROCEDURE TO PREPARE IT AND USE OF A PHARMACEUTICALLY ACCEPTABLE WEAK BASE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE OF THE SAME TO PREPARE SUCH ORAL DOSAGE FORM
TW092102772A TWI286079B (en) 2002-02-12 2003-02-11 Novel composition
PT03739557T PT1474114E (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
ES03739557T ES2336319T3 (en) 2002-02-12 2003-02-12 ORAL DOSAGE FORM FOR CONTROLLED RELEASE OF PHARMACOS.
EA200401071A EA008286B1 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
AU2003245763A AU2003245763B2 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
PL371368A PL206596B1 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
DE60331041T DE60331041D1 (en) 2002-02-12 2003-02-12 ORAL DOSAGE FOR THE CONTROLLED MEDICINAL RELEASE
SI200331764T SI1474114T1 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
EP03739557A EP1474114B1 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
AT03739557T ATE455540T1 (en) 2002-02-12 2003-02-12 ORAL DOSAGE FORM FOR CONTROLLED DRUG RELEASE
DK03739557.1T DK1474114T3 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled release of a drug
CNB038037378A CN100444833C (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
MXPA04007794A MXPA04007794A (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release.
KR1020047012361A KR101048925B1 (en) 2002-02-12 2003-02-12 Oral Dosage Forms for Controlled Drug Release
NZ534152A NZ534152A (en) 2002-02-12 2003-02-12 Controlled release oral dosage form comprising an erodable core containing a pharmaceutically active weak base
CA002475544A CA2475544A1 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
APAP/P/2004/003087A AP1736A (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release.
BRPI0307319A BRPI0307319B8 (en) 2002-02-12 2003-02-12 oral dosage form for controlled drug release and process for its preparation
PCT/GB2003/000594 WO2003068195A1 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
KR1020107015064A KR20100086084A (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
JP2003567378A JP2005526031A (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
CN2008101748461A CN101411693B (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release
OA1200400209A OA12770A (en) 2002-02-12 2003-02-12 Oral dosage form controlled drug release.
IL163098A IL163098A (en) 2002-02-12 2004-07-19 Oral dosage form for controlled drug release
IS7383A IS2747B (en) 2002-02-12 2004-08-05 Equipment for pulling fish right into the filleting machine
CO04077244A CO5601025A2 (en) 2002-02-12 2004-08-09 ORAL DOSAGE FORM PROVIDING CONTROLLED RELEASE
EC2004005232A ECSP045232A (en) 2002-02-12 2004-08-12 ORAL DOSAGE FORM, PROCEDURE TO PREPARE IT AND USE OF A PHARMACEUTICALLY ACCEPTABLE WEAK BASE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE OF THE SAME TO PREPARE SUCH ORAL DOSAGE FORM
MA27822A MA27689A1 (en) 2002-02-12 2004-08-12 ORAL GALENIC FORM FOR CONTROLLED DRUG DELIVERY
NO20043633A NO334453B1 (en) 2002-02-12 2004-08-31 Oral dosage form for controlled drug release, method of preparation and use thereof
HK05103523.5A HK1072194A1 (en) 2002-02-12 2005-04-25 Oral dosage form for controlled drug release
CL2007003010A CL2007003010A1 (en) 2002-02-12 2007-10-19 Oral dosage form comprising an erodible core that contains an active principle of a weak basic character, an erodible coating around said core with one or more openings that pass through the coating and connect the core with the means of use; preparation procedure; and use (divisional of 260-03).
CY20101100304T CY1109939T1 (en) 2002-02-12 2010-03-31 ORAL ORGANIZED DOSAGE FORM FOR CONTROLLED DRUG RELEASE
JP2010098906A JP5279757B2 (en) 2002-02-12 2010-04-22 Oral dosage form for controlled drug release
US12/966,323 US9144547B2 (en) 2002-02-12 2010-12-13 Oral dosage form for controlled drug release

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0203297A GB0203297D0 (en) 2002-02-12 2002-02-12 Novel composition

Publications (1)

Publication Number Publication Date
GB0203297D0 true GB0203297D0 (en) 2002-03-27

Family

ID=9930919

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203297A Ceased GB0203297D0 (en) 2002-02-12 2002-02-12 Novel composition

Country Status (1)

Country Link
GB (1) GB0203297D0 (en)

Similar Documents

Publication Publication Date Title
GB0220467D0 (en) Composition
GB0213638D0 (en) Composition
GB0212062D0 (en) Jetable compositions
GB0318894D0 (en) Composition
GB0208609D0 (en) Compositions
GB0203421D0 (en) Composition
GB0227244D0 (en) Composition
GB0208608D0 (en) Composition
GB0203296D0 (en) Novel composition
GB0203280D0 (en) Anti-glycolytic composition
GB0318824D0 (en) Novel composition
GB0305790D0 (en) Novel Composition
GB0211924D0 (en) Composition
GB0230274D0 (en) Composition
GB0218241D0 (en) Composition
GB0229808D0 (en) Novel compositions
GB0203396D0 (en) Compositions
HK1082517A1 (en) Oil-barrier composition
GB0217366D0 (en) Compositions
EP1495751A4 (en) Hairdye composition
GB0205786D0 (en) Novel Composition
GB0229286D0 (en) Composition
GB0228540D0 (en) Novel compositions
AU2003216382A8 (en) Idothyronine compositions
GB0213767D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)